Meglipride MP 2mg/500mg/15mg Tablet
Marketer
LifeCare Formulation Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Meglipride MP 2mg/500mg/15mg Tablet
Combiflex DM, a triple-combination tablet (2mg/500mg/15mg), effectively manages blood glucose. In conjunction with diet and exercise, it improves glycemic control in adult type 2 diabetics by enhancing insulin utilization and reducing blood sugar. Dosage and duration should strictly adhere to your physician's instructions. Administer with food to minimize gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose, in which case it should be omitted. Never double the dose; overdose can cause hypoglycemia. Concurrent use with other antidiabetic agents, alcohol consumption, or meal skipping elevates the hypoglycemia risk; regular blood glucose monitoring is crucial. Common adverse effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Renal function tests will be conducted before treatment initiation. Limit alcohol intake to mitigate potential side effects.
Primary Ingredients of Meglipride MP 2mg/500mg/15mg Tablet
No text was provided to rewrite.
Uses of Meglipride MP 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Meglipride MP 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Meglipride MP 2mg/500mg/15mg tablet whole; do not break, crush, or chew it. Administer this medication with food.
Common Side effects of Meglipride MP 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Meglipride MP 2mg/500mg/15mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Meglipride MP 2mg/500mg/15mg Tablet with food.
How Meglipride MP 2mg/500mg/15mg Tablet works:
Meglipride MP tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. This triple-action approach improves blood sugar management when single or dual medications prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood glucose. Metformin, a biguanide, acts via reduced hepatic glucose production, decreased intestinal glucose absorption, and enhanced insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Meglipride MP 2mg/500mg/15mg Tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Meglipride MP 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Meglipride MP 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Scant evidence from human studies indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Impaired driving may result from excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Meglipride MP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Meglipride MP 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Meglipride MP 2mg/500mg/15mg tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Meglipride MP 2mg/500mg/15mg Tablet :
Should you forget a Meglipride MP 2mg/500mg/15mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Meglipride MP 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently